EPISODE · Apr 29, 2026
U.S. Supreme Court Hikma Pharmaceuticals v. Amarin Pharma, Case No. 24-889
from Audio Arguendo · host U.S. Supreme Court
Administrative Law: When a generic drug label fully carves out a patented use, are allegations that the generic drugmaker calls its product a "generic version" and cites public information about the branded drug enough to plead induced infringement of the patented use? - Argued: Wed, 29 Apr 2026 13:44:54 EDT
NOW PLAYING
U.S. Supreme Court Hikma Pharmaceuticals v. Amarin Pharma, Case No. 24-889
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Feb 8, 2026 ·4m
Jan 30, 2026 ·6m
Jan 2, 2026 ·47m